Northstar Advisory Group LLC Invests $1.41 Million in iShares Biotechnology ETF $IBB

Northstar Advisory Group LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 8,328 shares of the financial services provider’s stock, valued at approximately $1,406,000.

Other large investors have also recently bought and sold shares of the company. BNP Paribas Financial Markets boosted its position in shares of iShares Biotechnology ETF by 313.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock worth $276,526,000 after purchasing an additional 1,451,820 shares in the last quarter. Jefferies Financial Group Inc. purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $65,083,000. JPMorgan Chase & Co. lifted its stake in shares of iShares Biotechnology ETF by 27.2% in the third quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock valued at $153,039,000 after purchasing an additional 226,852 shares during the period. Millennium Management LLC lifted its stake in shares of iShares Biotechnology ETF by 140.8% in the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after purchasing an additional 143,893 shares during the period. Finally, Caption Management LLC purchased a new stake in iShares Biotechnology ETF during the third quarter worth about $11,333,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $161.86 on Tuesday. The firm’s 50-day moving average is $171.00 and its two-hundred day moving average is $164.50. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.